Coley Pharmaceutical Group, Inc.
Records under this name other than the patents Coley Pharmaceutical Group, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Coley Pharmaceutical Group, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,354,522 | Immunostimulatory oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,153,141 | Immunostimulatory G, U-containing oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,662,949 | Immunostimulatory oligoribonucleotides Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,227,447 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,466,124 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,128,944 | RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,248,127 | Aqueous Gel Formulations Containing Immune Response Modifiers Formerly held In force · High confidence | In force | High confidence | |
| US 10,456,463 | Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,846,710 | Method of Preferentially Inducing the Biosynthesis of Interferon Formerly held Lapsed on the fee record Ended Sep 30, 2026 · High confidence | Lapsed on the fee record | Ended Sep 30, 2026 | High confidence |
| US 8,697,873 | Amide Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines Formerly held Lapsed on the fee record Ended Apr 15, 2026 · High confidence | Lapsed on the fee record | Ended Apr 15, 2026 | High confidence |